Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wen W Ma

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
World Journal of Gastroenterology|November 9, 2007
Exploiting novel molecular targets in gastrointestinal cancersWen W Ma, Manuel Hidalgo
Drugs of Today (Barcelona, Spain : 1998)|April 27, 2007
Strategies for suppressing angiogenesis in gynecological cancersWen W Ma, Antonio Jimeno
Drugs of Today (Barcelona, Spain : 1998)|November 8, 2007
TemsirolimusWen W Ma, Antonio Jimeno
Journal of Gastrointestinal Oncology|July 20, 2012
Emerging therapies in pancreas cancerAdam Kotowski, Wen W Ma
CA: a Cancer Journal for Clinicians|March 13, 2009
Novel agents on the horizon for cancer therapyWen W Ma, Alex A Adjei
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2013
Multiple myeloma mimicking metastatic pancreas cancerTaimur Sher, Seema Bhat, Potjana Jitawatanarat, et al.
The AAPS Journal|October 12, 2012
Interactions of everolimus and sorafenib in pancreatic cancer cellsDipti K Pawaskar, Robert M Straubinger, Gerald J Fetterly, et al.
Pharmaceutical Research|November 16, 2012
Interactions of everolimus and sorafenib in whole blood lymphocyte proliferationDipti K Pawaskar, Robert M Straubinger, Gerald J Fetterly, et al.
Cancer Immunology, Immunotherapy : CII|October 14, 2014
A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic responseJason W-L Eng, Kathleen M Kokolus, Chelsey B Reed, et al.
Cancer Chemotherapy and Pharmacology|March 5, 2013
Synergistic interactions between sorafenib and everolimus in pancreatic cancer xenografts in miceDipti K Pawaskar, Robert M Straubinger, Gerald J Fetterly, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
World Journal of Gastroenterology|November 9, 2007
Exploiting novel molecular targets in gastrointestinal cancersWen W Ma, Manuel Hidalgo
Drugs of Today (Barcelona, Spain : 1998)|April 27, 2007
Strategies for suppressing angiogenesis in gynecological cancersWen W Ma, Antonio Jimeno
Drugs of Today (Barcelona, Spain : 1998)|November 8, 2007
TemsirolimusWen W Ma, Antonio Jimeno
Journal of Gastrointestinal Oncology|July 20, 2012
Emerging therapies in pancreas cancerAdam Kotowski, Wen W Ma
CA: a Cancer Journal for Clinicians|March 13, 2009
Novel agents on the horizon for cancer therapyWen W Ma, Alex A Adjei
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2013
Multiple myeloma mimicking metastatic pancreas cancerTaimur Sher, Seema Bhat, Potjana Jitawatanarat, et al.
The AAPS Journal|October 12, 2012
Interactions of everolimus and sorafenib in pancreatic cancer cellsDipti K Pawaskar, Robert M Straubinger, Gerald J Fetterly, et al.
Pharmaceutical Research|November 16, 2012
Interactions of everolimus and sorafenib in whole blood lymphocyte proliferationDipti K Pawaskar, Robert M Straubinger, Gerald J Fetterly, et al.
Cancer Immunology, Immunotherapy : CII|October 14, 2014
A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic responseJason W-L Eng, Kathleen M Kokolus, Chelsey B Reed, et al.
Cancer Chemotherapy and Pharmacology|March 5, 2013
Synergistic interactions between sorafenib and everolimus in pancreatic cancer xenografts in miceDipti K Pawaskar, Robert M Straubinger, Gerald J Fetterly, et al.
Pageof 2